JM

Joseph McPherson

Vice President, Facilities Operations at Infinity Pharmaceuticals

No bio yet

Location

Cambridge, United States

Links


Org chart


Teams

This person is not in any teams


Offices


Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.